从ACCP指南看血栓综合治疗策略__培训课件.pptVIP

在DVT治疗中LMWH与UFH的比较 Relative risk (RR), LWMH versus UFH with 95% confidence interval * The RR reduction was only statistically significant for nadroparin Symptomatic recurrent VTE: RR = 0.53 (0.18-0.73), n=1086, p 0.01* Major bleeding: RR = 0.68 (0.31-0.85), n=1512, p 0.005 Overall mortality: RR = 0.47 (0.10-0.69), n=1086, p 0.04 1 2 0.5 1.5 0 2.5 Lensing A.W.A. et al. Arch Intern Med. 1995;155:601-7 LWMH better UFH better (10 comparative studies) Please send me the reference from Lensing. Tasman study : 门诊使用速碧凝预防DVT的有效性和安全性 % VTE recurrence* Major bleeding** Overall mortality***